CClinicalTrials.gg
Status unknownNCT03496935BACKDOORUpdated Apr 12, 2018

Tunneled Dialysis Catheters Versus Non-tunneled Dialysis Catheters as First-line for Renal Replacement Therapy in the ICU

An interventional study of Tunneled versus non-tunneled dialysis catheter insertion in Acute Kidney Injury, sponsored by Brigham and Women's Hospital. Status unknown. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2018-04-12.

Sponsored by Brigham and Women's Hospital · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Apr 2018), so the status shown — last known as Not yet recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
102
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The investigators propose a randomized controlled trial to examine whether tunneled dialysis catheters should be first-line for acute kidney injury requiring renal replacement therapy (AKI-RRT) in the critical care setting, barring any clinical contraindications, compared to non-tunneled access. This randomized controlled trial will include patients admitted to an intensive care unit (ICU) at Brigham and Women's Hospital (BWH). The investigators will randomize all eligible consented incident patients with AKI requiring renal replacement therapy either to tunneled dialysis catheter or non-tunneled dialysis catheter placement. The inclusion criteria encompasses all adult patients in the BWH ICUs with an incident AKI requiring renal replacement therapy. The investigators' hypothesis is that the rate of overall complications is lower with tunneled dialysis catheters compared to non-tunneled catheters.

Read the detailed description

Acute kidney injury (AKI) is defined by an abrupt decrease in kidney function resulting in the retention of urea and other nitrogenous waste products and in the dysregulation of extracellular volume and electrolytes. AKI is common, harmful and potentially treatable.

Despite decades of research, renal replacement therapy (RRT) in the form of dialysis remains the primary therapy to treat AKI and its complications. Due to convenience of scheduling and distribution of expertise, non-tunneled dialysis catheters have generally been the first-line source of vascular access for patients requiring acute dialysis for AKI in the ICU setting. However, there is evidence that tunneled dialysis catheters are associated with improved outcomes compared to non-tunneled dialysis catheters.

The investigators for this proposed trial performed an observational study at Brigham and Women's Hospital in 2016 comparing outcomes from temporary dialysis catheter versus tunneled dialysis catheter use for renal replacement therapy in the ICU.12 They found that there was a significant increase in median venous and arterial access pressure between temporary dialysis catheters and tunneled dialysis catheters for patients on CVVH with an increased rate ratio of interruptions and decreased blood flow rates for temporary dialysis catheters compared to tunneled dialysis catheters

The investigators now propose a prospective randomized controlled trial to examine whether tunneled dialysis catheters should be first-line for AKI-RRT in the critical care setting, barring any clinical contraindications, compared to non-tunneled access. This RCT will include patients admitted to an ICU at Brigham and Women's Hospital. The investigators will randomize all eligible consented incident patients with AKI requiring renal replacement therapy either to tunneled dialysis catheter or non-tunneled dialysis catheter placement. The inclusion criteria encompasses all adult patients in the BWH ICUs with an incident AKI requiring renal replacement therapy. Exclusion criteria will include 1) clinical instability requiring bedside catheter placement; 2) international normalized ratio (INR) >2.0 or other significant coagulopathy; 3) pending blood cultures within 48 hours or active bacteremia; or 4) urgency of line placement warranting placement within 6 hours. To avoid bias introduced by operator performance, the same group of interventional nephrologists will be utilized to place the catheters in both arms of the trial. The investigators' hypothesis is that the rate of overall complications is lower with tunneled dialysis catheters compared to non-tunneled catheters. Other secondary outcomes of interest include dialysis delivery parameters including access pressures and blood flow rates. The investigators also plan to assessing the feasibility of tunneled dialysis catheter placement for AKI, by capturing data on time to placement, resource utilization and cost. The proposal challenges a common clinical practice; placement of non-tunneled catheters for RRT initiation, which is not evidence-based, to determine if tunneled catheters can improve outcomes for patients compared to usual care.

The investigators will identify all patients with AKI requiring vascular access by reviewing inpatient renal consult patient lists and electronic orders for intermittent hemodialysis (IHD) or continuous renal replacement therapy (CRRT) initiation. Data will be prospectively collected on demographics, comorbidities, laboratory data, and microbiology results on a daily basis. Data will also be abstracted from procedure notes to identify procedural complications. Similarly, CVVH and IHD data (blood flow rates, venous and arterial pressures, total time of RRT per session, and number of interruptions during RRT) will be gathered prospectively on a daily basis from RRT flowsheets and RRT nursing notes. Patients will be followed throughout the entirety of the hospitalization until hospital discharge or death.

02

Conditions studied

  • Acute Kidney Injury

Browse trials for

Keywords

  • Renal replacement therapy
03

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

All adult patients in the BWH ICUs with an incident AKI requiring renal replacement therapy

Exclusion criteria

Exclusion Criteria:

  1. Clinical instability requiring bedside catheter placement
  2. INR >2.0 or other significant coagulopathy
  3. Pending blood cultures within 48 hours or active bacteremia
  4. Urgency of line placement warranting placement within 6 hours.
04

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
102 participants (estimated)

Study arms

  • Active comparator
    Tunneled dialysis catheter

    In this arm, patients will be randomized to undergo tunneled dialysis catheter insertion.

    Device: Tunneled versus non-tunneled dialysis catheter insertion

  • Active comparator
    Non-tunneled dialysis catheter

    In this arm, patients will be randomized to undergo non-tunneled dialysis catheter insertion.

    Device: Tunneled versus non-tunneled dialysis catheter insertion

Interventions

  • DeviceTunneled versus non-tunneled dialysis catheter insertion

    The study participants will be randomized either to tunneled or non-tunneled dialysis catheter insertion to commence renal replacement therapy for an acute kidney injury requiring either continuous or intermittent dialysis in the ICU.

05

What researchers measure

Primary outcomes

  1. Rate of complications

    Composite outcome including rate of infection and thrombosis. The incidence of both of these adverse events will be added together to give a composite rate of complications.

    Time frame: Up to 60 days

Secondary outcomes

  1. Dialysis venous access pressure

    Median venous access pressure

    Time frame: Up to 60 days

  2. Dialysis arterial access pressure

    Median arterial access pressure

    Time frame: Up to 60 days

  3. Dialysis blood flow rate

    Median blood flow rate

    Time frame: Up to 60 days

  4. Feasibility of tunneled catheter placement for AKI

    Time to catheter placement

    Time frame: Up to 60 days

  5. Cost of dialysis access placement for AKI

    Cost of dialysis catheter placement

    Time frame: Up to 60 days

06

Study locations

No study locations are listed for this record.

07

References and documents

Publications

  • Tsujimoto Y, Miki S, Shimada H, Tsujimoto H, Yasuda H, Kataoka Y, Fujii T. Non-pharmacological interventions for preventing clotting of extracorporeal circuits during continuous renal replacement therapy. Cochrane Database Syst Rev. 2021 Sep 14;9(9):CD013330. doi: 10.1002/14651858.CD013330.pub2. PubMed 34519356 ↗

Individual participant data

Plan to share: No

08

Registry details

Key details

Study ID
NCT03496935
Lead sponsor
Brigham and Women's Hospital
Responsible party
Yvelynne Kelly M.D. MSc. (Nephrology Fellow, Brigham and Women's Hospital) — Principal investigator
First posted
Apr 12, 2018
Start date
Jul 1, 2018 (estimated)
Primary completion
Jul 1, 2020 (estimated)
Completion
Sep 1, 2020 (estimated)
Last update
Apr 12, 2018

Study contacts

Yvelynne P Kelly, M.D. MSc.
Contact
ypkelly@bwh.harvard.edu
857-350-0573
Mallika Mendu, M.D. MBA.
principal investigator · Brigham and Women's Hospital

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Apr 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion